Search - tctmd.com

Displaying 441 - 460 of 6853

Sort: Relevancy | Date

Presentation NY Valves 2025

Latest Clinical Insights: Bridging Evidence and Practice

Presenter: Samir R. Kapadia

June 25, 2025

Presentation NY Valves 2025

Optimizing TAVR in Bicuspid Patients with DASI

Presenter: Hasan Jilaihawi

June 25, 2025

Presentation NY Valves 2025

Efficacy of CEP Devices to Reduce Stroke during TAVR: Insights From the TVT Registry

Presenter: David J. Cohen

June 25, 2025

Presentation NY Valves 2025

Mitigating Stroke Risk in TAVR: Global Burden and the Role of Embolic Protection

Presenter: Suzanne J. Baron

June 25, 2025

Presentation NY Valves 2025

Simplified UNICORN for High-risk Valve-in-Valve TAVR

Presenter: Raviteja Reddy Guddeti

June 25, 2025

Presentation NY Valves 2025

Advantages of Splitting Bicuspid Aortic Valve Leaflets Prior to TAVR: A New Paradigm for Leaflet Modification in BAV?

Presenter: Hasan Jilaihawi

June 25, 2025

Presentation NY Valves 2025

TAVR Reintervention Strategies: Unveiling Trends and Outcomes of Redo TAVR and TAVR Explant

Presenter: Shinichi Fukuhara

June 25, 2025

Presentation NY Valves 2025

Repeat Interventions Following Transcatheter Aortic Valve Replacement: A Comparative Analysis of Redo TAVR and Surgical Explantation

Presenter: Chloe Kharsa

June 25, 2025

Presentation NY Valves 2025

High Risk Coronary Obstruction TAVR in SAVR

Presenter: Itsik Ben-Dor

June 25, 2025

Presentation NY Valves 2025

Valve-in-Valve TAVR Using the Navitor Transcatheter Heart Valve

Presenter: Dustin Kliner

June 25, 2025

Presentation NY Valves 2025

"Bi-Unicorn" ViViV TAVR

Presenter: Obrad Kokanovic

June 25, 2025

Presentation NY Valves 2025

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Presenter: Allan Schwartz

June 25, 2025

Presentation NY Valves 2025

Two Deliveries in One Day: Cesarean Section Followed by an Immediate Valve-in-Valve TAVR in a Patient With Congenital Heart Disease and Bioprosthetic Valve Failure

Presenter: Faisal Alkhatib Tamimi

June 25, 2025

Presentation NY Valves 2025

First Report of Successful TAVR in a Failed Prior Ozaki Aortic Valve Reconstruction

Presenter: Ahmed Ghoneem

June 25, 2025

Presentation NY Valves 2025

Outcomes of Patients 75 Years and Older With Bicuspid vs Tricuspid Aortic Valves Undergoing TAVR

Presenter: Tamari Lomaia

June 25, 2025

Presentation NY Valves 2025

Considerations for TAVR-First or SAVR-First Strategies in Young Patients

Presenter: Mayra Guerrero

June 25, 2025

Presentation NY Valves 2025

Do It Once, Do It Right: A Step-by-Step Workflow for Fast, Maximally Efficient and Safest IVL-Assisted TF TAVR

Presenter: Christopher Cook

June 25, 2025

Presentation NY Valves 2025

Comparison Self-Expanding THV With Intra-Annular Versus Supra-Annular Design for Valve-in-Valve TAVR

Presenter: Dustin Kliner

June 25, 2025

Presentation NY Valves 2025

PRO – TAVR: 3 Reasons Why TAVR Is the Best Option for This Patient

Presenter: Isaac George

June 25, 2025

Presentation NY Valves 2025

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Presenter: Raj Makkar

June 25, 2025

Advertisement

Latest Clinical Insights: Bridging Evidence and Practice

Optimizing TAVR in Bicuspid Patients with DASI

Efficacy of CEP Devices to Reduce Stroke during TAVR: Insights From the TVT Registry

Mitigating Stroke Risk in TAVR: Global Burden and the Role of Embolic Protection

Simplified UNICORN for High-risk Valve-in-Valve TAVR

Advantages of Splitting Bicuspid Aortic Valve Leaflets Prior to TAVR: A New Paradigm for Leaflet Modification in BAV?

TAVR Reintervention Strategies: Unveiling Trends and Outcomes of Redo TAVR and TAVR Explant

Repeat Interventions Following Transcatheter Aortic Valve Replacement: A Comparative Analysis of Redo TAVR and Surgical Explantation

High Risk Coronary Obstruction TAVR in SAVR

Valve-in-Valve TAVR Using the Navitor Transcatheter Heart Valve

"Bi-Unicorn" ViViV TAVR

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Two Deliveries in One Day: Cesarean Section Followed by an Immediate Valve-in-Valve TAVR in a Patient With Congenital Heart Disease and Bioprosthetic Valve Failure

First Report of Successful TAVR in a Failed Prior Ozaki Aortic Valve Reconstruction

Outcomes of Patients 75 Years and Older With Bicuspid vs Tricuspid Aortic Valves Undergoing TAVR

Considerations for TAVR-First or SAVR-First Strategies in Young Patients

Do It Once, Do It Right: A Step-by-Step Workflow for Fast, Maximally Efficient and Safest IVL-Assisted TF TAVR

Comparison Self-Expanding THV With Intra-Annular Versus Supra-Annular Design for Valve-in-Valve TAVR

PRO – TAVR: 3 Reasons Why TAVR Is the Best Option for This Patient

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content